Treatment With Tucatinib in Patients With an Isolated Brain Progression of a Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer With a Isolated Brain Progression
Interventions: DRUG: Tucatinib|DRUG: Pertuzumab|DRUG: Trastuzumab|DRUG: Hormone therapy|DRUG: Pertuzumab/ Trastuzumab
Sponsor: UNICANCER
Collaborators: Seagen Inc.|ARCAGY/ GINECO GROUP